Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.00
Bid: 150.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.667%)
Open: 155.00
High: 155.00
Low: 155.00
Prev. Close: 155.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

Mon, 27th Apr 2020 13:51

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Novacyt SA - clinical diagnostics - Wins deal to supply Covid-19 testing kits to the UK Department of Health. To initially provide tests for six months. Committed to supply 288,000 tests per week for NHS use.

----------

Byotrol PLC - infection prevention - Continues to see exceptional demand across all markets due to the Covid-19 pandemic. Predicts strong demand to continued to at least the first quarter of year ending March 31, 2021, and likely beyond. Strong order book exceeding GBP2 million and expects record product sales in the first quarter. Estimates revenue of GBP6.0 million for financial 2020 and adjusted earnings before interest, tax, depreciation and amortisation of GBP250,000. Cash of GBP1.7 million at March-end.

----------

Mind Gym PLC - behavioural science - Expects revenue for year ended March 31 to rise 15% to GBP48.2 million and adjusted pretax profit between GBP5.8 million and GBP7.3 million. Furloughs some employees and 20% salary cuts implemented among workforce and directors. Founding directors forego 100% of salary.

----------

Omega Diagnostics Group PLC - allergy testing - Says partner Mologic Ltd's Covid-19 antibody test receives regulatory CE-mark. Omega to now work towards manufacturing 46,000 Covid-19 tests per day.

----------

Venture Life Group PLC - self-care products - Inks 15-year pact worth EUR168 million with partner for distribution of Dentyl mouthwash products in greater China. Says demand was high before and after Covid-19 outbreak in China.

----------

EKF Diagnostics PLC - healthcare products - Says demand for PrimeStore MTM sample collection device boosted amid pandemic. First quarter trading exceeded expectations and on-track for full-year growth.

----------

Faron Pharmaceuticals Oy - biopharmaceuticals - Reports Traumakine respiratory drug to be included in World Health Organization's Solidarity trial for potential Covid-19 treatments.

----------

Hostelworld Group PLC - hostel operator - Reports Covid-19 outbreak has caused significant disruption in travel market. First quarter earnings before interest, tax, depreciation and amortisation down by about USD4.8 million year-on-year and second quarter booking volumes minimal.

----------

Camellia PLC - agriculture - Says all operations bar India running close to full capacity. Some tea auctions have been cancelled in recent weeks and tea prices poor in first quarter due to overproduction in 2019, but sees some signs of increased demand amid virus crisis. Engineering business running close to full capacity but says all of UK Food Service have been forced to furlough some staff.

----------

Union Jack Oil PLC and Reabold Resources PLC - hydrocarbon producer and oil & gas investor - Both note operator of West Newton A-2 well receives positive decision from UK regulators. Testing operations at West Newton to commence after Covid-19 movement curbs subside. Reabold has 39% stake in West Newton, Union Jack has 17% interest.

----------

Serinus Energy PLC - gas producer - Executive directors take 20% pay cut due to virus crisis and commodity price crash. Will receive company shares to top up salary. Non-executive to take 25% cut in fees.

----------

Petroneft Resources PLC - oil & gas producer - Reports successful re-entry of C-3 well in Cheremshanskoye field, Russia. Well re-entry programmes suspended due to pandemic.

----------

Anglo Pacific Group PLC - natural resources - Says Covid-19 has had minimal impact on royalties in first quarter. Says total portfolio contribution in first quarter down 1.6% quarter-on-quarter to GBP12.6 million.

----------

ADM Energy PLC - oil & gas investor - Says social distancing measures adopted in offices. Putting in place measures for immediate 35% cut in general and administrative expenses. Unclear on how Covid-19 and commodity price falls will affect investment level.

----------

Aminex PLC - oil & gas producer - Names Non-Executive Robert Ambrose as interim chief executive officer. Says focus on fixed-price sales contracts protected it from oil price falls but adds delays in Tanzania operations likely due to movement restrictions. Granted extension on Ruvuma licence, Tanzania. Investor Solo Oil PLC, with 25% stake in Ruvuma, noted licence extension.

----------

Chaarat Gold Holdings Ltd - gold miner - Closes placing, raising USD13.8 million. Says placing conducted to strengthen finances amid challenging market.

----------

Yu Group PLC - utilities supplier to businesses - Launches Assist and Agile energy plans for businesses hurt by Covid-19. Both plans allow for reduced energy prices.

----------

Staffline Group PLC - recruiter - Names Ian Lawson as executive chair effective immediately, replacing Chris Pullen. Says demand in food sector surged, but slumped in manufacturing, retail and automotive. Has furloughed some staff where possible.

----------

SimplyBiz Group PLC - compliance and business services - Implements cost savings like freezing spend, halting pay rises and cutting director salaries. Confirms final dividend for 2019 but rules out interim 2020 dividend. Withdraws full-year guidance. Non-Executive Director Gary Hughes to become deputy chair with immediate effect.

----------

Trakm8 Holdings PLC - data insight - Says revenue for year to March 31 in line with guidance, 2% higher at GBP19.6 million. Says Covid-19 delayed hardware shipments, and meant that negotiations with UK-based food retailer were not completed.

----------

System1 Group PLC - online market research - Expects fourth quarter sales revenue to fall by a quarter and by 2% in year to end of March. Has furloughed some staff and adds that board and other senior executives have agreed to defer 20% of salaries.

----------

Quartix Holdings PLC - vehicle tracking software - Says initial impact on earnings from pandemic was limited. Unable to provide annual guidance due to uncertainty. Trading in first quarter ended March in line with expectations.

----------

7digital Group PLC - digital music streaming - Implements cost cuts, saving GBP750,000 per month. Says Covid-19 has meant some first half contract wins pushed to second half.

----------

Accesso Technology Group PLC - software solutions - Says cost cuts mean monthly expenses reduced by USD2.6 million. Furloughs 50% of staff and cuts 29 additional full-time positions. Says pandemic has hit key markets, including North America, but backs rebound.

----------

Holders Technology PLC - products for printed circuit boards - Cuts planned final dividend by two-thirds to 0.25 pence per share from 0.75p per share to save costs amid pandemic.

----------

Windar Photonics PLC - wind sensors developer - Receives order for 30 WindVision systems in China. Says all employees agree to 20% monthly salary cut due to Covid-19.

----------

Filtronic PLC - antenna manufacturer - Says supply chain a concern but does not predict critical shortages of materials. Search for new CEO delayed due to virus. Does not expect a new CEO to join before its first quarter beginning June.

----------

Alumasc Group PLC - building products - Water Management to reopen sites in Burton Latimer, Northamptonshire, and Halstead, Essex, from Monday. Says some furloughed staff in Roofing and Levolux units to be brought back if demand allows.

----------

Springfield Properties PLC - housebuilder - Agrees an additional GBP18 million one-year loan with Royal Bank of Scotland, increasing total credit facility to GBP85 million. Says 90% of workforce furloughed and executive and non-executive directors agree to 50% reduction in salary.

----------

Macau Property Opportunities Fund Ltd - property investor - Says no new Covid-19 infections in Macau since April 9. Completes USD2.4 million disposal of a unit at One Central Residences skyscraper in Macau.

----------

SQN Secured Income Fund PLC - investment trust - To hold general meeting on continuation vote in June, unable to hold meeting in first quarter of 2020 due to Covid-19.

----------

Verditek PLC - green technology investor - Says Lainate in Italy commenced production on April 6, after employees self-isolated in line with government guidance. Signs deal to develop solar panel manufacturing site in Portugal.

----------

PCF Group PLC - specialist bank - Says virus had limited impact on first half, though future hurt expected. Says Covid-19 outbreak has reduced lending levels.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Mar 2024 11:52

Faron Pharmaceuticals reports year of clinical progress

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals reported a year of strong progress on Wednesday, with significant overall response rates seen in both previously hypomethylating agent (HMA)-failed and higher-risk myelodysplastic syndrome (MDS) patient populations in the phase one part of the BEXMAB study.

Read more
6 Mar 2024 16:06

UK earnings, trading statements calendar - next 7 days

Thursday 7 March 
Admiral Group PLCFull Year Results
Aviva PLCFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Coats Group PLCFull Year Results
Darktrace PLCHalf Year Results
Elementis PLCFull Year Results
Entain PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Harbour Energy PLCFull Year Results
ITV PLCFull Year Results
Kier Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
PageGroup PLCFull Year Results
Physiomics PLCHalf Year Results
Rentokil Initial PLCFull Year Results
Robert Walters PLCFull Year Results
Spirax-Sarco Engineering PLCFull Year Results
TT Electronics PLCFull Year Results
Tyman PLCFull Year Results
Friday 8 March 
Informa PLCFull Year Results
Just Group PLCFull Year Results
LMS Capital PLCFull Year Results
Stelrad Group PLCFull Year Results
Monday 11 March 
HgCapital Trust PLCFull Year Results
Mincon Group PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Tuesday 12 March 
BATM Advanced Communications LtdFull Year Results
Costain Group PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
Foresight Solar Fund LtdFull Year Results
Genuit PLCFull Year Results
H&T Group PLCFull Year Results
Hill & Smith PLCFull Year Results
MaxCyte IncFull Year Results
Persimmon PLCFull Year Results
Synthomer PLCFull Year Results
Target Healthcare REIT PLCHalf Year Results
TI Fluid Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
Wednesday 13 March 
4imprint Group PLCFull Year Results
Advanced Medical Solutions Group PLCFull Year Results
Balfour Beatty PLCFull Year Results
Centaur Media PLCFull Year Results
Faron Pharmaceuticals LtdFull Year Results
Ferrexpo PLCFull Year Results
Gym Group PLCFull Year Results
Hochschild Mining PLCFull Year Results
IP Group PLCFull Year Results
Keywords Studios PLCFull Year Results
Kin & Carta PLCHalf Year Results
Metro Bank Holdings PLCFull Year Results
Nexteq PLCFull Year Results
PensionBee Group PLCFull Year Results
Public Policy Holding Co IncFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Supermarket Income REIT PLCHalf Year Results
Trainline PLCTrading Statement
Vaalco Energy IncFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.

Read more
4 Mar 2024 19:59

TRADING UPDATES: Beowulf raises funds for Kallak iron ore project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Mar 2024 10:40

Faron Pharmaceuticals shores up cash with EUR 3.2m convertible loans

(Sharecast News) - Faron Pharmaceuticals announced on Monday that it has successfully secured binding commitments for convertible loans totalling €3.2m from a select group of existing shareholders.

Read more
27 Feb 2024 21:12

TRADING UPDATES: Armadale Capital eyes Mahenge project financing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
22 Feb 2024 14:26

UK earnings, trading statements calendar - next 7 days

Friday 23 February 
City of London Investment Group PLCHalf Year Results
Irish Residential Properties REIT PLCFull Year Results
Standard Chartered PLCFull Year Results
Monday 26 February 
Base Resources LtdHalf Year Results
Bunzl PLCFull Year Results
EnSilica PLCHalf Year Results
Kosmos Energy LtdFull Year Results
Made Tech Group PLCHalf Year Results
Tristel PLCHalf Year Results
Tuesday 27 February 
abrdn Equity Income Trust PLCFull Year Results
abrdn PLCFull Year Results
Croda International PLCFull Year Results
Kitwave Group PLCFull Year Results
McBride PLCHalf Year Results
PCI-PAL PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Synectics PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Wednesday 28 February 
AB Dynamics PLCTrading Statement
ASA International Group PLCTrading Statement
Aston Martin Lagonda Global Holdings PLCFull Year Results
Avingtrans PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Derwent London PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Grit Real Estate Income Group LtdHalf Year Results
Harmony Energy Income Trust PLCFull Year Results
Hutchmed China LtdFull Year Results
International Personal Finance PLCFull Year Results
Just Eat Takeaway.com NVFull Year Results
Primary Health Properties PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
RHI Magnesita NVFull Year Results
St James's Place PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Thursday 29 February 
Cairn Homes PLCFull Year Results
CVS Group PLCFull Year Results
Drax Group PLCFull Year Results
Faron Pharmaceuticals LtdFull Year Results
Haleon PLCFull Year Results
Hammerson PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Hunting PLCFull Year Results
International Biotechnology Trust PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Man Group PLCFull Year Results
Mobico Group PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
Ocado Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder Oriental Income Fund LtdFull Year Results
Schroders PLCFull Year Results
Serco Group PLCFull Year Results
Shaftesbury Capital PLCFull Year Results
Spectris PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Vesuvius PLCFull Year Results
Weir Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
19 Feb 2024 11:23

Faron discloses events of default on debt obligations to lender

(Alliance News) - Faron Pharmaceuticals Ltd shares fell on Monday, after it said it is in breach of several undertakings agreed in a secured debt deal with lender IPF Fund II SCA, SICAV-FIAR.

Read more
25 Jan 2024 20:09

TRADING UPDATES: Microsaic completes acquisition; Narf revenue soars

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 12:36

Faron launches second phase of leukaemia treatment trial

(Sharecast News) - Faron Pharmaceuticals has initiated phase two of the BEXMAB trial, it announced on Tuesday, marking a significant milestone in its cancer treatment development programme.

Read more
9 Jan 2024 10:56

Faron says first patient dosed in phase two Bexmab trial for cancer

(Alliance News) - Faron Pharmaceuticals Ltd on Tuesday announced that the first patient has been dosed in phase 2 of its Bexmab trial.

Read more
11 Dec 2023 13:22

Faron unveils promising antibody study results

(Sharecast News) - Faron Pharmaceuticals unveiled promising phase one data from its BEXMAB study in myeloid malignancies during the 65th American Society of Hematology (ASH) annual meeting, it announced on Monday.

Read more
11 Dec 2023 12:01

Faron Pharmaceuticals hails positive results of cancer drug trial

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said results from a probe of a cancer drug were promising.

Read more
7 Dec 2023 19:33

IN BRIEF: Faron Pharma celebrates publication of bexmarilimab results

Faron Pharmaceuticals Ltd - Finland-based clinical-stage biopharmaceutical company - Says that results from its Phase 1/2 MATINS trial of bexmarilimab have been published in Cell Reports Medicine, an open-access journal. According to the trial, bexmarilimab monotherapy shows efficacy in achieving disease control and prolonged survival in late-stage metastatic solid tumours. It also showed that CLEVER-1 targeting is safe and well-tolerated with no serious adverse effects, and that bexmarilimab induced macrophage activation and increased IFNy signalling in patients who achieved disease control and prolonged survival.

Read more
7 Dec 2023 11:01

Faron publishes cancer immunotherapy study findings

(Sharecast News) - Faron Pharmaceuticals announced the publication of the comprehensive findings from the groundbreaking phase one and two 'MATINS' trial of bexmarilimab on Thursday - its humanised monoclonal anti-CLEVER-1 antibody aimed at transforming the landscape of anticancer immunotherapies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.